Clinical Resources for Clinicians · For clinicians

IV Iron Prior Authorization: A Practical Guide for OB/GYN Offices

Many health plans require prior authorization for IV iron. Approval usually hinges on three things: lab-confirmed iron deficiency, a documented failed or contraindicated oral iron trial, and a formulation on the plan's preferred list. Build the documentation into the order itself, request expedited review when a pregnant patient is near term, and know your appeal options. Payer criteria vary and change often, so confirm current requirements plan by plan.

Why IV iron stalls at the paperwork

The clinical decision is usually quick. What eats the time is administrative: missing labs, an oral iron trial that happened but was never documented, a non-preferred product, or a fax sitting in someone's queue. For a patient at 34 weeks, a two-week authorization delay can be the difference between correcting anemia before delivery and arriving in labor with it.

Most of the delay is preventable, and most of the prevention happens before the request is ever submitted.

What payers typically want

Treat this as a checklist, not a guarantee; exact criteria vary by plan.

Element What to document
Diagnosis ICD-10 code for iron deficiency anemia; plus the pregnancy-complication or postpartum code where applicable
Labs Recent hemoglobin and ferritin; TSAT if ferritin is borderline or inflammation present; dates
Oral iron trial Product, dose, start date, duration, adherence
Reason oral iron is inadequate No Hb response after an adequate trial; intolerance (specific side effects); malabsorption (bariatric surgery, IBD, celiac); time-sensitive need
Clinical context Gestational age, EDD, planned delivery date; symptoms; ongoing blood loss
Product and dose Formulation, dose per infusion, number of infusions, total iron
Site of care Infusion center or office; some plans steer to specific sites

Write it so a reviewer can say yes

A medical reviewer reads dozens of these a day. Make yours easy:

  • Weak: "Patient failed oral iron."
  • Strong: "Ferrous sulfate daily from 6/2 to 7/1. Hb 9.4 → 9.5 g/dL, ferritin 9 µg/L. Patient now 31 weeks. Oral iron failure per ACOG PB 233 and BSH 2020 guidance; IV iron indicated in the second/third trimester."

Citing guidelines isn't required, but it shows the request meets accepted standards and tends to shorten the back-and-forth.

Intolerance counts, but name it. "GI upset" gets questioned; "constipation and nausea on daily ferrous sulfate and on alternate-day dosing, stopped after 3 weeks" usually doesn't.

Step therapy and formulary

Many plans name a preferred IV iron. Common patterns:

  • Lower-cost products, often iron sucrose, may be preferred, with higher-cost single-dose products needing an exception.
  • Exceptions are often granted for documented reasons: a prior reaction to the preferred product, the need to complete repletion in fewer visits because of late gestational age or access barriers, or a documented contraindication.

When you request a non-preferred product, lead with the clinical reason. In late pregnancy, "fewer visits needed to complete repletion before planned delivery" is a legitimate one. And be pragmatic: if time is tight, the preferred product approved today usually beats your preferred product approved in two weeks.

Expedited review

Most plans offer urgent or expedited review when the standard timeline could seriously jeopardize the patient's health, with a much shorter decision window. Federal and New York rules set these timelines for regulated plans. Ask for it when:

  • The patient is in the third trimester with anemia that won't correct before delivery
  • The patient is postpartum with moderate to severe symptomatic anemia
  • Anemia is severe enough that delay raises transfusion risk

Spell out the urgency ("Delay of standard review risks delivery with uncorrected anemia and increased transfusion risk") and include gestational age and planned delivery date. Reviewers can't infer urgency from a hemoglobin alone.

New York Medicaid and managed care

New York Medicaid pregnancy coverage, delivered mostly through managed care plans, covers medically necessary prenatal and postpartum care, and the state extended postpartum Medicaid coverage to 12 months. Each managed care plan sets its own prior authorization process and formulary for physician-administered drugs. Check that plan's provider manual; don't assume fee-for-service rules apply. In a practice that sees patients across several Medicaid plans, this is exactly why the payer grid below matters.

Denials we see most, and the fix

Denial reason Fix
Labs too old or missing ferritin Include labs from the last 30–60 days with ferritin
No oral iron trial documented Document product, dates and outcome, or why oral is inappropriate
Non-preferred product Request formulary exception with clinical reason, or switch
Site-of-care restriction Use an in-network infusion center the plan approves
Diagnosis code mismatch Use iron deficiency anemia codes consistent with labs; add pregnancy codes
Quantity exceeds limit Show iron deficit calculation and planned total dose

Peer-to-peer and appeals

  • Peer-to-peer: request it promptly after a denial. Have gestational age, labs, oral trial details and the guideline rationale in front of you. Many denials are overturned here, often in a few minutes.
  • Internal appeal: a letter of medical necessity with supporting records.
  • External appeal: New York's Department of Financial Services runs external appeals for state-regulated plans. Self-funded employer plans follow federal rules. Watch the deadlines.

A letter of medical necessity, in eight lines

Short, specific, easy to scan:

  1. Patient and request: name, plan ID, product, dose and number of infusions
  2. Diagnosis: iron deficiency anemia complicating pregnancy (or postpartum), with codes
  3. Supporting data: dated hemoglobin, ferritin and TSAT
  4. Prior treatment: oral iron product, dose, dates and outcome
  5. Clinical rationale: why IV iron now, including gestational age, delivery date and symptoms
  6. Guideline support: one line referencing ACOG and hematology guidance supporting IV iron after oral iron failure in the second and third trimesters
  7. Urgency statement, if requesting expedited review
  8. Clinician signature and direct contact for peer-to-peer

Keep it as an EHR template so staff fill in specifics instead of starting from scratch.

When no authorization is needed

Some plans don't require prior auth for certain products, sites of care or diagnoses. Have benefits verification confirm that before the infusion rather than assuming it; that quick check prevents retroactive denials and surprise bills for patients.

Record approval numbers, approved dose and expiry dates, because a delayed infusion can fall outside the window. Note whether the approval covers a repeat course if ferritin stays low, which is common with ongoing losses or malabsorption.

Making it routine

  1. An EHR order set for IV iron that requires the key fields: labs, oral trial, reason, gestational age.
  2. A payer grid for your top plans: preferred products, PA forms, turnaround times, site-of-care rules. Update it quarterly.
  3. One owner for IV iron authorizations, so requests don't sit in a shared inbox.
  4. An infusion partner whose team handles benefits verification and authorization. For many OB offices this is the single biggest time saver.
  5. Track order-to-infusion time. The outpatient anemia protocol lists audit measures.

Clinical criteria: IV iron in pregnancy and when oral iron fails.

Referral partnership in New York

Handing authorization work to an infusion partner frees your staff and gets patients treated sooner. Premier Hematology & Oncology, which sponsors our professional resources, offers referral pathways, IV iron infusions and co-management for OB/GYN practices across New York. See our hematology partners page for how referrals are coordinated.

Frequently asked questions

Does IV iron need prior authorization?

Often, yes. Many commercial and managed Medicaid plans require prior authorization for IV iron, especially for higher-cost formulations, and some require trying a preferred product first.

What documentation do payers want for IV iron?

Typically a diagnosis of iron deficiency or iron deficiency anemia with lab values (hemoglobin, ferritin and/or TSAT), evidence of an oral iron trial with failure or intolerance, or a documented reason oral iron is inappropriate.

Can prior authorization be expedited in pregnancy?

Most plans offer an urgent or expedited review when a standard timeline could seriously jeopardize the patient's health. Late-pregnancy anemia with delivery approaching is a reasonable basis to request one, with the clinical rationale documented.

What is step therapy for IV iron?

A payer rule that requires a preferred, usually lower-cost, IV iron product to be tried or ruled out before a non-preferred one is covered. Exceptions are usually possible with documented clinical reasons.

Sources

  • ACOG — Anemia in Pregnancy (Practice Bulletin No. 233)
  • British Society for Haematology — UK guidelines on the management of iron deficiency in pregnancy (2020)
  • CMS — Medicare Prior Authorization and Medicaid managed care requirements (general program guidance)
  • New York State Department of Financial Services — Utilization review and external appeal (consumer and provider guidance)

This article is for general education and is not medical advice. It does not replace an evaluation by a licensed clinician who knows your history. If you think you have a medical emergency, call 911.